Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CYP1B1 |
| Upstream (Parents) |
|---|
| (<<) CASP1 → CYP1B1 |
| (<<) CDR2 → CYP1B1 |
| (<<) CKB → CYP1B1 |
| (<<) CRKL → CYP1B1 |
| (<<) FZD2 → CYP1B1 |
| (<<) INPP5D → CYP1B1 |
| (<<) KCTD12 → CYP1B1 |
| (<<) KYNU → CYP1B1 |
| (<<) LIPG → CYP1B1 |
| (<<) NFKBIA → CYP1B1 |
| (<<) NFKBIE → CYP1B1 |
| (<<) PDE2A → CYP1B1 |
| (<<) PIK3CD → CYP1B1 |
| (<<) PIK3R5 → CYP1B1 |
| (<<) PTGS1 → CYP1B1 |
| (<<) PTK7 → CYP1B1 |
| (<<) ROCK2 → CYP1B1 |
| (<<) SIN3A → CYP1B1 |
| (<<) SQLE → CYP1B1 |
| (<<) STEAP1 → CYP1B1 |
| (<<) TNFAIP3 → CYP1B1 |
| (<<) VAV1 → CYP1B1 |
| Downstream (Children) |
|---|
| CYP1B1 → BMP8B (>>) |
| CYP1B1 → CXCL2 (>>) |
| CYP1B1 → EFEMP1 (>>) |
| CYP1B1 → FCRLB (>>) |
| CYP1B1 → HS2ST1 (>>) |
| CYP1B1 → IL1R1 (>>) |
| CYP1B1 → ITPR3 (>>) |
| CYP1B1 → LOC100131262 (>>) |
| CYP1B1 → SPRY2 (>>) |
| CYP1B1 → YWHAG (>>) |
